SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
Generated Narrative: Organization SampleLabelerOrganization
identifier: urn:oid:1.3.6.1.4.1.519.1
/999999999, urn:oid:2.16.840.1.113883.6.69
/55555
type: An organization that submits product labels.
name: National Pharma of India Inc.
Purpose | Name | Telecom | Address |
Administrative | Charles Smith | +011-703-362-1280, charles@anywhere.com | 123 IVY LANE ROAD SMITH FALLS MD 12345 USA |
123 IVY LANE ROAD SMITH FALLS MD 12345 USA |
Generated Narrative: OrganizationAffiliation #SampleLabelerUSAgentAffiliation
organization: Organization National Pharma of India Inc.
participatingOrganization: Organization National Pharma of India Inc. US Agent
code: UNITED STATES AGENT
Generated Narrative: Organization #usagent
identifier:
urn:oid:1.3.6.1.4.1.519.1
/888888888type: An organization that acts on the behalf of a Labeler or Establishment in the US.
name: National Pharma of India Inc. US Agent
Contacts
Telecom +1-908-999-1212, jdoe_2@npoiinc.net
Generated Narrative: HealthcareService #SampleLabelerBusinessOperation
providedBy: Organization National Pharma of India Inc.
type: manufacture
serviceProvisionCode: Manufactures human prescription drug products